Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Faster than Your Auto-Injector: Aquestive’s Sublingual Epinephrine Film Aces New Clinical Trials

Fecal Transplants Reveal a New Path Toward Peanut Allergy Treatment

Breakthroughs on the Horizon: FAF Funds Five New Studies Targeting Food Allergies

Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

As Food Allergy Treatments Become Big Business, Pharma Bets on VT-7208

FDA Authorizes Moderna Vaccine, Another Pfizer Vaccine Recipient Has Allergic Reaction

Moderna COVID-19 Vaccine List of Ingredients

Healthcare Worker in Alaska Suffers Anaphylactic Reaction After Pfizer COVID-19 Immunization

FDA Panel Deems Moderna COVID-19 Vaccine ‘Highly Effective’, No Serious Allergic...

Peanut Allergy Vaccine Takes Step Closer With Grant from Government of...

Viaskin Peanut “Patch” Therapy Takes Next Step Toward Approval… in Europe

Emergency Epinephrine Film Begins Phase 1 Clinical Trials

Aquestive’s Sublingual Epinephrine Film Receives FDA Fast Track Designation for Treatment...

Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode

FDA Denies Approval of Viaskin Peanut “Patch” Therapy

Follow Us

Your School On Our Map

Put Your School on the Map